Thermo Fisher Scientific Enables Ireland’s First Fragment-Based Screening Programme
University of Dublin Selects Maybridge Ro3 Diversity Fragment Library for Drug DiscoveryThermo Fisher Scientific Inc., the world leader in serving science, today announced that the University of Dublin has purchased the Maybridge Ro3 Diversity Fragment library for use in a new drug discovery program. As an institution known for its world-class biomedical research, the University is the first organization in the Republic of Ireland to undertake a fragment-based screening programme. With possible applications in the fight against viral replication, bacterial infections and Alzheimer’s disease, this research has the potential to provide significant therapeutic advances.
Dr. Neil Ferguson’s team – the UCD Biomolecular Interactions Group – combines state-of-the-art biophysical and structural biology methodologies to unravel the molecular structures and forces that cause human diseases. By incorporating the Maybridge Ro3 library into his existing multi-disciplinary approach, Dr. Ferguson adds a new dimension to his team’s research and their ability to identify potential drug compounds. The Ro3 library will enable the team to pursue challenging targets (such as those incompatible with conventional HTS programmes), neglected diseases and, in many cases, new targets emerging from his basic research programmes.
“Combining the power of fragment-based drug discovery with our high-end instrumentation, we can effectively tackle our ever-expanding portfolio of therapeutic targets,” said Dr. Ferguson. “Our aim is to identify novel leads that can develop into next-generation therapeutics. I gave long and serious consideration to the fragment library that we would use for this new initiative. Among the key criteria were the chemical diversity, validated solubility profiles and a proven track record in hit identification. The ready availability of its components in bulk format and their superior stability also makes the Maybridge Ro3 library an excellent choice for further development of the downstream medicinal chemistry.”
Dr. Ferguson concluded, “We feel that our current skill set, therapeutic targets, biophysical infrastructure and the Maybridge Ro3 library all place us well to make a serious fragment-based drug discovery effort within the academic sphere – watch this space!”
The Maybridge Ro3 Diversity Fragment library is a resource of more than 1500, hand-selected, compound fragments and small molecule pharmacophores. Selection criteria include the compliance with the “Rule of Three” (Ro3) for lead generation and for the superior solubility profile of the compound. This highly diverse fragment library is available as three 500-compound sets; each compound in the library is pre-solubilised as a 1 mL, 10 mM solution, providing 10 µMol of 95 percent purity material dissolved in analytical grade DMSO.
For further information on this product please visit www.maybridge.com.
About Maybridge Products
The Maybridge product line, part of Thermo Fisher Scientific, features highly innovative drug-like molecules and screening compounds for drug discovery and development. Available for both lab and development scale, the offering continually expands with the production of novel heterocyclic and phenyl ring-based chemical building blocks, including a unique and growing range of reactive intermediates. For more information about Maybridge brand products visit www.maybridge.com or call +44 18 40 77 05 67.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.
Alto Marketing
Alto Marketing Limited| Office 3 Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL | UK
Media Contact Information:
Name: Sarah Perceval, Alto Marketing
Phone: +44 (0)1489 557672
Email: sarahp@alto-marketing.com
Secondary Contact Information:
Simon Pearce, Thermo Fisher Scientific
Tel: +44 (0)1840 772077
simon.pearce@thermofisher.com
www.maybridge.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thermo Fisher Scientific Enables Ireland’s First Fragment-Based Screening Programme here
News-ID: 175442 • Views: …
More Releases from Thermo Fisher Scientific
Thermo Fisher Scientific Provides the Last Line of Defense against Mycoplasma Co …
New 1-Liter Unit Offers Rapid, High-Capacity Filtration of Cell Culture Media
Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its Thermo Scientific Nalgene 0.1 Micron PES Filter line with a new 1-liter unit, offering customers the broadest size selection on the market for 0.1 micron vacuum filtration of cell culture media to prevent mycoplasma contamination. The new unit incorporates a large 90 mm diameter membrane and…
Thermo Fisher Scientific Offers Energy Efficient Sample Storage
New Thermo Scientific Revco UxF Series of Ultra-low Temperature Freezers Maximize Sample Storage Capacity While Minimizing Energy Usage
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Thermo Scientific Revco UxF Series of ultra-low temperature (ULT) freezers. These innovative new freezers have been designed to provide laboratories with an energy efficient approach to cold storage. The Revco® UxF portfolio incorporates your choice of a high-performance or…
Thermo Fisher Scientific Launches New, Highly Efficient Cryogenic Storage Soluti …
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new Thermo Scientific CryoExtra high-efficiency cryogenic storage containers, which provide greater sample-storage capacity in a smaller footprint.
The CryoExtra™ vacuum-insulated, stainless steel vessels are available in four different sizes, from 407 liters to 1,630 liters, accommodating both vapor- and liquid-phase storage. These containers minimize top-to-bottom temperature variation, preserving the integrity of critical cryogenically frozen samples. Its innovative lid…
Thermo Fisher Scientific Provides Rapid and Efficient Nucleic Acid Purification
Informative Thermo Scientific KingFisher Nucleic Acid Purification Kits Online Video Provides an Educational Overview of the Powerful, Flexible System
Thermo Fisher Scientific Inc., the world leader in serving science, has released an educational video on its new range of Thermo Scientific KingFisher nucleic acid purification kits for enhanced sample processing. The new kits combine seamlessly with the Thermo Scientific KingFisher magnetic particle processors to maximize the speed and efficiency of user…
More Releases for Maybridge
Thermo Fisher Scientific Screening Library Advances Drug Discovery Research at T …
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Moulder Center for Drug Discovery Research at Temple University’s School of Pharmacy has selected the company’s Maybridge screening libraries to identify compounds that might be useful in treating health problems as diverse as Alzheimer’s disease, cancer and drug dependency.
Thermo Fisher will…
Thermo Fisher Scientific Expands Maybridge Ro3 Diversity Fragment Library
Maximises Effectiveness in Structure-Based Drug Discovery
Thermo Fisher Scientific, the world leader in serving science, today announced that it has expanded its Maybridge Ro3 Diversity Fragment Library, to make it an even more powerful tool for structure-based drug discovery.
The new library adds 1,000 Ro3 (Rule of 3) compliant molecules, complementing the 1,500 compounds introduced last year. This expansion increases the diversity of the library by more than 30…
Thermo Fisher Scientific Introduces “Off the Shelf” Fragment Library for Tim …
Maybridge Ro3 Diversity Fragments now available in prepared stock solution format for convenient use at the bench top
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Maybridge Ro3 Diversity Fragment Library is now available in a new prepared format, with each compound pre-dissolved as a DMSO solution.
A gold standard for lead generation, the Maybridge Ro3 Diversity Fragment Library contains a broad range of 1,500…